Myriad Genetics revenue

Myriad Genetics revenue decreased from $772.6 million in 2018 to $N/A in 2019, a 100% decrease.

Annual Revenue ($)

Myriad Genetics revenue was $772.60 m in FY, 2018 which is a 0.4% year over year increase from the previous period.

Quarterly Revenue ($)

FY, 2016FY, 2017FY, 2018
Revenue$740.50 m$769.90 m$772.60 m
Growth2.41%3.97%0.35%
Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018Q1, 2019Q2, 2019
Revenue$183.50 m$193.30 m$190.50 m$177.50 m$196.50 m$196.90 m$178.80 m$187.90 m$193.50 m$202.30 m$216.80 m

Annual Growth Rate (%)

Revenue Breakdown

Business Segment

Myriad Genetics revenue breakdown by business segment: 93.1% from Diagnostics and 6.9% from Other

FY, 2016FY, 2017FY, 2018
Diagnostics692.40 m720.60 m719.30 m
Other48.10 m49.30 m53.30 m